Euro Observer, Summer 2008, Vol.10, No.2
نویسنده
چکیده
Payers in Europe and North America have embraced generic medicines because of their perceived cost advantages in relation to branded products and the savings they create to health insurance. A robust body of evidence exists to date pointing at savings achieved through genericization. All stakeholders accept that realizing these savings is desirable as health systems face continuous cost pressures and demands to invest in new technologies.
منابع مشابه
Euro Observer, Summer 2007, Vol.9, No.2
Between 2004 and 2050, Europe’s population aged 65 and over is projected to rise sharply, by 58 million (approximately 77%), and the fastest-growing segment of the population will be the very old (aged 80+).1 This rapid growth in the older population will have a major effect on the demand for, and supply of, long-term care services. While improvements in overall health have been realized, many ...
متن کاملEuro Observer Autumn 2008, Vol.10, No.3
Although Member States retain the primary responsibility for organization and delivery of health services under Article 152 of the EC Treaty, this policy space is still shaped by Community law and policy. The Community did not have legal authority in the field of public health until 1999, when the public health article was amended and renumbered by the Treaty of Amsterdam as the current Article...
متن کاملEuro Observer, Winter 2007, Vol.9, No.4
Little is known about access to health care among the 35 to 40 million foreign-born people in Europe. Indeed, the European Commission has found that “While Member States identify immigrants among those particularly at risk of poverty and social exclusion, many countries still fail to provide in-depth analysis of the factors leading to this situation. Little attention is given to promoting acces...
متن کاملEuro Observer, Winter 2008, Vol.10, No.4
The concept of a medical savings account – in its purest form, a vehicle to allow people to save money to spend on health care – was initially developed in the United States in the 1970s. In the 1980s and 1990s the concept was translated into policy in a handful of countries, either as part of a private health insurance market (South Africa and the US) or to complement publicly-financed health ...
متن کاملEuro Observer Autumn 2006, Vol.8, No.3
Originally, screening was introduced as a public health measure to detect conditions such as tuberculosis which might be a health hazard to the community. Since then demand for screening has greatly increased. It is now considered applicable to the prevention of disease and is considered to be a logical extension of medical practice. However, it has become apparent that there are also disadvant...
متن کامل